Model Number 37612 |
Device Problems
Failure to Interrogate (1332); Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017); Low Battery (2584); Battery Problem (2885); Charging Problem (2892); Communication or Transmission Problem (2896)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 04/01/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a consumer regarding a patient who was implanted with an implantable neurostimulator (ins) for dystonia.It was reported the implant was not charging and stated their ins recharger was not letting them find a place to charge sometime in 2017.The patient also stated they were trying to find out their implant battery level using their patient programmer but reported seeing poor communication screen.The patient stated their last successful recharge was in (b)(6) of 2017 because they had been ill (unrelated to therapy/device).There was a suspected overdischarge.The patient services specialist (pss) reviewed that the patient needs to reach out to their healthcare professional to resolve the issue.No patient symptoms or further complications were reported as a result of this event.
|
|
Manufacturer Narrative
|
Device used for off label indication.The indication the device was used for was dystonia.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a manufacturing representative.The manufacturing representative alleged the ins was overdischarged and called in for instructions on performing a physician mode reset of the patient¿s ins.It was stated that there was no communication with the programmer or recharger.Technical services reviewed the steps in bringing the ins out of overdischarge, and to not turn the device on before it reaches a 25% charge.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep).It was reported that patient has not charged their implantable neurostimulator (ins) in about 2 months.Patient was not able to get the charger to connect and doesn't know if this is because of user error or ins position/depth since an old kinetra pocket was used for this implant.The rep thinks the patient has had one or 2 over discharge (od) events in the past, around 3+years ago.The od recovery process was reviewed for the rep.The rep reported that patient has a preop appointment on (b)(6), with a possible ins replacement on (b)(6).
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|